Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/17212
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSANYAL, Shreosi-
dc.contributor.authorVANCAUTEREN, Mark-
dc.date.accessioned2014-10-07T10:17:37Z-
dc.date.available2014-10-07T10:17:37Z-
dc.date.issued2014-
dc.identifier.citationInnovation Forum VI - 2014, Crisis, innovation and transition, Paris, France, 1-3 October, 2014-
dc.identifier.urihttp://hdl.handle.net/1942/17212-
dc.language.isoen-
dc.titleR&D and its determinants: A study of the pharmaceutical firms in the Netherlands-
dc.typeConference Material-
local.bibliographicCitation.conferencedate2014, October 1-3-
local.bibliographicCitation.conferencenameInnovation Forum VI - 2014, Crisis, innovation and transition-
local.bibliographicCitation.conferenceplaceParis, France-
local.bibliographicCitation.jcatC2-
local.type.refereedRefereed-
local.type.specifiedConference Material-
item.contributorSANYAL, Shreosi-
item.contributorVANCAUTEREN, Mark-
item.fullcitationSANYAL, Shreosi & VANCAUTEREN, Mark (2014) R&D and its determinants: A study of the pharmaceutical firms in the Netherlands. In: Innovation Forum VI - 2014, Crisis, innovation and transition, Paris, France, 1-3 October, 2014.-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.